Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Altheia Science logo — Altheia Science develops treatments for autoimmune diseases...

Altheia Science

Altheia Science develops treatments for autoimmune diseases and cancer using innovative tools. Founded by renowned Italian scientists.

Founded 2017 Italy Italy 6 employees Series A Total: $11.00M Biotechnology, Health Care +1

General Information

Company Name Altheia Science
Founded Year 2017
Location Italy Italy +2
Employees 6
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series A
Social

Get notified when Altheia Science moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Altheia Science

Altheia Science is a cutting-edge biotechnology startup headquartered in Italy, founded in 2017 by renowned Italian scientists Prof. Alessandra Biffi, MD and Prof. Paolo Fiorina, MD, PhD along with AurorA-TT. The company specializes in developing innovative treatments for autoimmune diseases and cancer using pioneering therapeutic tools. Its approach involves the modulation of PD-L1 expression at the molecular and protein level, aiming to achieve tangible and durable benefits for each patient. Altheia Science secured a significant $11.00M Series A investment on 24 September 2018 from Rottapharm Biotech. With its groundbreaking approach and strong backing, Altheia Science is poised to make a substantial impact in the fields of biotechnology and healthcare.

Taxonomy: gene therapy, autoimmunity, autoimmune diseases, cancer, cell therapy, gene editing, PD-L1 modulation, lentiviral vector, hematopoietic stem cells, innovation, Italian biotech company, treatment development, immunotherapy, precision medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1
Investor
24 Sep 2018

Altheia Science Alternatives & Competitors

Altheia Science vs
Tune Therapeutics
Tune Therapeutics United States

Mastering the epigenome, unlocking complex disease.

Series B
67 employees
Biotechnology
Altheia Science vs
CAMP4 Therapeutics
CAMP4 Therapeutics United States

Advancing a pipeline of ASO-based, RNA-targeting therapeutics with the aim to restore healthy protei...

Unknown
62 employees
Biopharma, Biotechnology
Altheia Science vs
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. United States

A privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunothe...

Series Unknown
26 employees
Biotechnology, Health and Wellness

FAQ About Altheia Science

Altheia Science develops treatments for autoimmune diseases and cancer using innovative tools. Founded by renowned Italian scientists.
Altheia Science was founded in 2017.
Altheia Science is headquartered in Italy.
Altheia Science operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Altheia Science has approximately 6 employees.
Altheia Science has completed 1 funding round, raising a total of $11.00M. The latest funding stage is Series A.
Top alternatives and competitors to Altheia Science include Tune Therapeutics, CAMP4 Therapeutics, Immunomic Therapeutics, Inc., Alentis Therapeutics, YouthBio Therapeutics Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Altheia Science and Tune Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Altheia Science and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes